Hinge Health, Inc. (HNGE)
Healthcare • Health Information Services
StockNYSEUnited StatesUS4333131039
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Hinge Health, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:45. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Feb 2027 16:00 | 0.73 | — | — | Upcoming |
| 02 Nov 2026 16:00 | 0.60 | 0.71 | +19.0% | Beat |
| 04 Aug 2026 16:00 | 0.62 | 0.59 | -4.1% | Miss |
| 05 May 2026 16:00 | 0.40 | 0.45 | +13.3% | Beat |
| 10 Feb 2026 16:00 | 0.43 | 0.49 | +15.2% | Beat |
| 04 Nov 2025 16:00 | 0.24 | 0.44 | +81.6% | Beat |
| 05 Aug 2025 16:00 | 0.09 | 0.70 | +710.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 587.9M | +50.6% | -528.3M | -89.9% | -7.77 | -4,979.9% | 165.4M |
| 2024 | 390.4M | +33.4% | -11.9M | -3.1% | -0.15 | +90.3% | 45.2M |
| 2023 | 292.7M | — | -108.1M | -36.9% | -1.58 | — | -68.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 116.22 | 126.40 | 112.80 | 114.35 | -1.22% | 5,694,014 | |
| 02 Nov 2026 – 06 Nov 2026 | 115.75 | 124.94 | 111.00 | 115.76 | +1.26% | 12,749,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 111.69 | 117.55 | 110.49 | 114.32 | +2.51% | 9,260,800 | |
| 19 Oct 2026 – 23 Oct 2026 | 100.31 | 113.48 | 99.99 | 111.52 | +12.46% | 11,899,800 | |
| 12 Oct 2026 – 16 Oct 2026 | 102.29 | 107.00 | 97.44 | 99.16 | -3.63% | 7,292,000 | |
| 05 Oct 2026 – 09 Oct 2026 | 99.00 | 103.28 | 96.02 | 102.90 | +5.35% | 11,349,300 | |
| 28 Sep 2026 – 02 Oct 2026 | 93.98 | 99.73 | 91.52 | 97.67 | +2.20% | 7,026,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 95.08 | 96.45 | 89.75 | 95.57 | +0.71% | 7,551,000 | |
| 14 Sep 2026 – 18 Sep 2026 | 88.69 | 96.66 | 88.53 | 94.90 | +7.12% | 12,343,700 | |
| 08 Sep 2026 – 11 Sep 2026 | 91.88 | 93.76 | 86.29 | 88.59 | -4.09% | 7,859,300 | |
| 68 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Hinge Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 12 Nov 2026 18:02
- Bull of the Day: Hinge Health, Inc. (HNGE) (opens in a new tab) Zacks · 10 Nov 2026 08:00
- Hinge Health and Tripadvisor have been highlighted as Zacks Bull and Bear of the Day (opens in a new tab) Zacks · 10 Nov 2026 05:29
- Earnings Estimates Rising for Hinge Health Inc. (HNGE): Will It Gain? (opens in a new tab) Zacks · 09 Nov 2026 16:20
- Best Momentum Stocks to Buy for November 9th (opens in a new tab) Zacks · 09 Nov 2026 14:15
- Hinge Health Consensus Price Target Raised 18.03% to $136.49 (opens in a new tab) Fintel · 09 Nov 2026 13:59
- Hinge Health (HNGE) Stock Looks Stretched On Its 156% YTD Run (opens in a new tab) Simply Wall St. · 04 Nov 2026 07:11
- Why Everyone Is Watching Hinge Health (HNGE) Now (opens in a new tab) Simply Wall St. · 04 Nov 2026 04:32
- Why This Top 1% IPO Stock, A Telehealth Giant, Advanced On Its Earnings (opens in a new tab) Investor's Business Daily · 03 Nov 2026 21:32
- Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135 (opens in a new tab) Benzinga · 03 Nov 2026 16:54
- Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131 (opens in a new tab) Benzinga · 03 Nov 2026 13:34
- Hinge Health, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 03 Nov 2026 13:30
- Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145 (opens in a new tab) Benzinga · 03 Nov 2026 12:53
- Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132 (opens in a new tab) Benzinga · 03 Nov 2026 11:27
- RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135 (opens in a new tab) Benzinga · 03 Nov 2026 11:00
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 120.99 USD
- Market cap
- 9.8B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 16.7 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 20.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.3 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 9.6 / 10 |
|
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 32.97× | Weak | 30.56× |
| P/E (forward) | 37.16× | Weak | 14.16× |
| Price / book | 32.82× | Weak | 3.5× |
| Price / sales | 12.28× | Weak | 3.33× |
| EV / EBITDA | 62.54× | Weak | 11.19× |
| Free cash flow yield | 3.2% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 85.8% | Good | 54.9% |
| Operating margin | 18.8% | Good | 5.8% |
| Net margin | 21% | Good | 1.2% |
| Return on equity | 47.6% | Good | 4.4% |
| Return on assets | 11.4% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 41.7% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.11× | Good | 0.4× |
| Net debt / EBITDA | -1.7× | Good | 1.46× |
| Current ratio | 1.04× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow HNGE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.